Neuron Bio Information

Neuron Bio (ticker: NEU) is the parent company of a group of R&D companies that develop research in two areas of biotechnology: the Biopharmaceutical sector (Neuron Biolabs) and the Bioindustrial sector (Neol Bio). Neuron Bio is listed in the Alternative Stock Market (ASM) in Spain. Neuron Biolabs develops biosolutions for application in the pharmaceutical and agri-food industries through its specialised divisions. The Pharma division is dedicated fundamentally to the search for preventative drugs and treatments for neurodegenerative diseases, particularly Alzheimer’s disease. The Diagnostic division develops tools and biomarkers for the diagnosis of diseases of the Central Nervous System, as in the case of Alzheimer’s. The Services Division offers a wide range of R&D services in the fields of biomedicine, toxicology and agri-food. Neol Bio is dedicated to the development of innovative biotechnological, industrial microbial processes for application in different sectors: functional food, oleochemistry, bioenergy and other bioproducts. These processes have been developed for clients and as internal R&D projects. Amongst the technologies that Neol Bio has developed is an exclusive platform for the production of high-value oils which has culminated in the creation of Neol Nutritional Products, a company dedicated to the production and commercialisation of high-quality Omega-3 DHA Oil with microalgae selected by Neol Bio.